PREPARE-IT. Prevention and Treatment of COVID19 With EPA in Subjects at Risk - Intervention Trial
Status:
Completed
Trial end date:
2021-08-30
Target enrollment:
Participant gender:
Summary
The PREPARE-IT investigator-initiated trial program is a simple, pragmatic, therapeutic
strategy evaluating pure icosapent ethyl (IPE) at initially higher doses intended to reduce
infection rates and subsequent morbidity and mortality among subjects at high risk of
infection due to COVID-19 (prevention arm), and to reduce the hospitalization rate and
complications in patients with a positive diagnosis of COVID-19 (treatment arm).